G2 checkpoint abrogator abates the antagonistic interaction between antimicrotubule drugs and radiation therapy

Radiotherapy and Oncology

Volumn 104, Issue 2, 2012, Pages 243-248

  Sui, Meihua ^a,b   Zhang, Hongfang ^b   Di, Xiaoyun ^c   Chang, Jinjia ^a   Shen, Youqing ^b   Fan, Weimin ^a,d  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG CANCER HOSPITAL   (China)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Antimicrotubule drugs; Apoptosis; Breast cancer; Cell cycle arrest; Radiation therapy; UCN 01

Indexed keywords

PACLITAXEL; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOCHEMISTRY; BREAST CANCER; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CYTOTOXICITY; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL DEATH; CELL DIVISION; CELL LINE, TUMOR; CHEMORADIOTHERAPY; DNA FRAGMENTATION; FEMALE; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; MICROTUBULES; PACLITAXEL; RADIATION, IONIZING; STAUROSPORINE; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 84865800234     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.04.021     Document Type: Article

References (18)

1. K.S. Choe, J.K. Salama, and K.M. Stenson Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer Radiother Oncol 97 2010 318 321
2. W. Fan Possible mechanisms of paclitaxel-induced apoptosis Biochem Pharmacol 57 1999 1215 1221
3. T. Terasima, and L.J. Tolmach Variations in several responses of HeLa cells to x-irradiation during the division cycle Biophys J 3 1963 11 33
4. L. Milas, N.R. Hunter, K.A. Mason, B. Kurdoglu, and L.J. Peters Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel Cancer Res 54 1994 3506 3510
5. M. Raitanen, V. Rantanen, and J. Kulmala Paclitaxel combined with fractionated radiation in vitro: a study with vulvar squamous cell carcinoma cell lines Int J Cancer 97 2002 853 857
6. M. Loprevite, R.E. Favoni, and A. de Cupis Interaction between novel anticancer agents and radiation in non-small cell lung cancer cell lines Lung cancer 33 2001 27 39
7. M. Sui, J.M. Dziadyk, X. Zhu, and W. Fan Cell cycle-dependent antagonistic interactions between paclitaxel and gamma-radiation in combination therapy Clin Cancer Res 10 2004 4848 4857
8. M. Sui, and W. Fan Combination of gamma-radiation antagonizes the cytotoxic effects of vincristine and vinblastine on both mitotic arrest and apoptosis Int J Radiat Oncol Biol Phys 61 2005 1151 1158
9. M. Osmak Multifactorial molecular mechanisms are involved in resistance of preirradiated human cervix carcinoma cells to cis-dichlorodiammineplatinum (II) and vincristine Neoplasma 40 1993 97 101
10. C. Grau, M. Hoyer, and J. Overgaard The in vivo interaction between vincristine and radiation in a C3H mammary carcinoma and the feet of CDF1 mice Int J Radiat Oncol Biol Phys 30 1994 1141 1146
11. K.A. Mason, L. Milas, and L.J. Peters Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa Int J Radiat Oncol Biol Phys 32 1995 1381 1389
12. A.H. Ree, A. Bratland, R.V. Nome, T. Stokke, O. Fodstad, and Y. Andersson Inhibitory targeting of checkpoint kinase signaling overrides radiation-induced cell cycle gene regulation: a therapeutic strategy in tumor cell radiosensitization? Radiother Oncol 72 2004 305 310
13. C.C. Kuo, H.P. Hsieh, and W.Y. Pan BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo Cancer Res 64 2004 4621 4628
14. M. Schmidt, H.P. Hofmann, K. Sanders, G. Sczakiel, T.L. Beckers, and V. Gekeler Molecular alterations after Polo-like kinase 1 mRNA suppression versus pharmacologic inhibition in cancer cells Mol Cancer Ther 5 2006 809 817
15. T. Kawabe G2 checkpoint abrogators as anticancer drugs Mol Cancer Ther 3 2004 513 519
16. K. Sugiyama, M. Shimizu, and T. Akiyama UCN-01 selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G(2) checkpoint abrogation Int J Cancer 85 2000 703 709
17. M.V. Blagosklonny Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs Oncogene 21 2002 6249 6254
18. V. Aaltonen, J. Koivunen, M. Laato, and J. Peltonen PKC inhibitor Go6976 induces mitosis and enhances doxorubicin-paclitaxel cytotoxicity in urinary bladder carcinoma cells Cancer Lett 253 2007 97 107